Close Menu

aneuploidy

NEW YORK (GenomeWeb News) - Sequenom today announced that it has signed several distribution deals outside of the US that will expand access to the firm's MaterniT21 PLUS testing service outside the United States.

NEW YORK (GenomeWeb News) – Tufts Health Plan will begin covering Sequenom's MaterniT21 Plus trisomy 21 test and Pathwork Diagnostics' Tissue of Origin test starting Oct. 1.

NEW YORK (GenomeWeb News) – Sequenom announced after the close of the market on Thursday that revenues spiked 38 percent year over year during the second quarter as the MaterniT21 Plus fetal aneuploidy test continued to see strong adoption.

NEW YORK (GenomeWeb News) – Sequenom said after the close of the market on Monday that it has appealed a decision by a federal court denying Sequenom's request for a preliminary injunction against Ariosa Diagnostics.

NEW YORK (GenomeWeb News) – With the arrival over the past year of several new prenatal genetic diagnostic tests and recent advances in sequencing the fetal genome, genomic medicine has begun to show how it may be used to diagnose diseases in fetuses early in pregnancy and with high accuracy, but

The story has been updated to include comments by Sequenom.
NEW YORK (GenomeWeb News) – Ariosa Diagnostics today said that Sequenom's motion for a preliminary injunction against it has been denied by a federal court.

Belgian molecular diagnostics firm Multiplicom said this week that it has been awarded €200,000 ($250,000) from the Flemish agency for Innovation by Science and Technology to develop a blood-based non-invasive molecular diagnostic test for fetal aneuploidy.

NEW YORK (GenomeWeb News) – Belgian molecular diagnostics firm Multiplicom today said it has been awarded €200,000 ($250,000) to develop a blood-based non-invasive fetal aneuploidy test.

NEW YORK (GenomeWeb News) – Coventry Health Care National Network has terminated its coverage agreement with Sequenom covering the MaterniT21 Plus test, just one week after the agreement was announced, the San Diego-based molecular diagnostics firm said after the close of the market on Thursday.

NEW YORK (GenomeWeb News) – Sequenom today said that health insurance provider Coventry Health Care National Network will provide coverage for its T21 test.

Pages

As the Canadian election season heats up, neither major party has really paid much attention to science, according to Nature News.

BBC News says the uncertainty over Brexit is affecting science funding in the UK.

A new app purports to tell users "how gay" they are by looking at their DNA, but experts tell Futurism that the app is bunk.

In Nature this week: human and great ape cerebral organoids reveal aspects of brain development unique to humans, and more.